Craft

Shanghai Shenqi Pharmaceutical

Stock Price

¥8.4

2024-10-29

Market Capitalization

¥4.1 B

2024-10-29

Revenue

¥1.9 B

FY, 2025

Shanghai Shenqi Pharmaceutical Summary

Company Summary

Overview
Shenqi Pharmaceutical (also known as Shanghai Shenqi Pharmaceutical Investment Management, 神奇制药投资管理股份有限公司) is a pharmaceutical holding company specialized in the research, manufacturing, and distribution of medicine. The company is focused on anti-tumor, cardiovascular, and pediatric medications.
Type
Public
Status
Active
Founded
1983
HQ
Shanghai, CN | view all locations
Website
http://www.gzsq.com
Cybersecurity rating
Sectors

Key People

  • Feng Bin, GM & Director

    • Kejing Wu, Board Secretary

      • Zhimian Chen, CFO & Director

        • Zhang Taotao

          Zhang Taotao, Chairman

          LocationsView all

          1 location detected

          • Shanghai, Shang Hai Shi HQ

            China

            Room 613, Changfa Building, No. 128 Weihai Road

          Shanghai Shenqi Pharmaceutical Financials

          Summary Financials

          Revenue (Q1, 2026)
          ¥412.9M
          Gross profit (Q1, 2026)
          ¥180.8M
          Net income (Q1, 2026)
          ¥12.0M
          Cash (Q1, 2026)
          ¥482.4M
          EBIT (Q1, 2026)
          ¥19.9M
          Enterprise value
          $3.7B

          Footer menu